SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration
Under Section 12(g) of the Securities Exchange Act of 1934
or Suspension of Duty to File Reports Under Sections 13 and
15(d) of the Securities Exchange Act of 1934
Commission File Number 1-10740
National Health Laboratories Incorporated
(Exact name of registrant as specified in its charter)
4225 Executive Square, Suite 800
La Jolla, California 92037
(619) 550-0600
(Address, including zip code, and telephone number,
including area code, of registrant's principal
executive offices)
Common Stock ($.01 par value)
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the
appropriate rule provision(s) relied upon to terminate or
suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [X]
Approximate number of holders of record as of the
certification or notice date: 1
<PAGE>2
Pursuant to the requirements of the Securities
Exchange Act of 1934, National Health Laboratories
Incorporated has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized
person.
Date: July 20, 1994 By: /s/James G. Richmond
--------------------------
Name: James G. Richmond
Title: Executive Vice
President and
General Counsel
